Cite
Filippov SK, Khusnutdinov RR, Inham W, et al. Hybrid Nanoparticles for Haloperidol Encapsulation: Quid Est Optimum?. Polymers (Basel). 2021;13(23)doi: 10.3390/polym13234189.
Filippov, S. K., Khusnutdinov, R. R., Inham, W., Liu, C., Nikitin, D. O., Semina, I. I., Garvey, C. J., Nasibullin, S. F., Khutoryanskiy, V. V., Zhang, H., & Moustafine, R. I. (2021). Hybrid Nanoparticles for Haloperidol Encapsulation: Quid Est Optimum?. Polymers, 13(23), . https://doi.org/10.3390/polym13234189
Filippov, Sergey K, et al. "Hybrid Nanoparticles for Haloperidol Encapsulation: Quid Est Optimum?." Polymers vol. 13,23 (2021). doi: https://doi.org/10.3390/polym13234189
Filippov SK, Khusnutdinov RR, Inham W, Liu C, Nikitin DO, Semina II, Garvey CJ, Nasibullin SF, Khutoryanskiy VV, Zhang H, Moustafine RI. Hybrid Nanoparticles for Haloperidol Encapsulation: Quid Est Optimum?. Polymers (Basel). 2021 Nov 30;13(23). doi: 10.3390/polym13234189. PMID: 34883693.
Copy
Download .nbib